KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
$0.612
+0.0363 (+6.31%)
At Close: Apr 26, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

The Daily Biotech Pulse: KemPharm, FDA Nod For Merck, Clovis Q3 Miss, 3 Stocks To Debut

 12:00am, Wednesday, 31'st Oct 2018

Stocks Which Set New 52-Week Low Yesterday, October 29th

 12:00am, Tuesday, 30'th Oct 2018

Stocks Which Set New 52-Week Low Friday, October 26th

 12:00am, Monday, 29'th Oct 2018

58 Biggest Movers From Friday

 12:00am, Monday, 22'nd Oct 2018

BioLineRx Discloses Additional Data from Phase 2a COMBAT/KEYNOTE-202 Study in Pancreatic Cancer Showing BL-8040 Significantly Improves T-cell Infiltration Into the Tumor and Reduces Immunosuppression in the Tumor Microenvironment at ESMO 2018

 12:00am, Saturday, 20'th Oct 2018

UPDATE: BioLineRx Says 'Triple combination expansion cohort (BL-8040 + KEYTRUDA® (pembrolizumab) + chemotherapy) to commence by year-end'

 12:00am, Friday, 19'th Oct 2018

The Week Ahead In Biotech: ESMO Conference, PDUFA Dates, Clinical Trial Results And IPOs

 12:00am, Sunday, 14'th Oct 2018

Stocks Which Set New 52-Week High Yesterday, October 4th

 12:00am, Friday, 05'th Oct 2018

BioLineRx Stock Up on Stake Increase in Lead Cancer Program

 12:00am, Thursday, 04'th Oct 2018

BioLineRx Raises Stake In Its Oncology Platform, BL-8040, From 60% To 80%

 12:00am, Wednesday, 03'rd Oct 2018

Portola's (PTLA) Lymphoma Candidate Gets Orphan Drug Status

 12:00am, Wednesday, 26'th Sep 2018

Bioline Rx Q2 EPS $(0.05) Beats $(0.06) Estimate

 12:00am, Monday, 13'th Aug 2018

BioLineRx Reports The First 11 Patients In BL-8040 In Comibnation With Standard Treatment Is Safe An Tolerable And That 9/11 Patients Reached Primary Endpoint

 12:00am, Tuesday, 07'th Aug 2018

Your Daily Pharma Scoop: Theravance Positive, Denali Encouraging, Redhill Clarifies Data

 12:00am, Thursday, 02'nd Aug 2018

BioLineRx Initiates Phase 1/2a Clinical Study For AGI-134, A Novel Immunotherapy For Treatment Of Solid Tumors

 12:00am, Wednesday, 01'st Aug 2018
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE